Hints and tips:
...There are already two Fresenius arms on the index, both part of one healthcare group....
...SE cut to “equal-weight” at Barclays; Geberit downgraded to “sell” at Berenberg; Glanbia rated “underweight” at Morgan Stanley; Hapag-Lloyd cut to “hold” at Deutsche Bank; ING upgraded to “neutral” at Credit...
...SE raised to “neutral” at UBS; LafargeHolcim upgraded to “neutral” at Davy; MedicX cut to “sell” at Stifel; Medios rated “buy” at Berenberg; Prudential downgraded to “sell” at Société Générale; Saint-Gobain...
...But size per se is looking less attractive....
..., the European company said in a statement: “Fresenius SE & Co KGaA confirms that Fresenius Kabi is currently in discussions with Akorn, Inc., a US specialty generic pharmaceutical company, concerning a...
...The challenge to Tykerb’s patents in India was brought by Fresenius Kabi Oncology, the Indian unit of German healthcare group Fresenius SE....
...The recent slump in the share price of Fresenius Medical Care, a company where Warren Buffett is a 14 per cent shareholder, was triggered by a US government decision to reduce payments for dialysis treatment...
...Smarting from the failure of its €3bn offer for Rhön Klinikum, Fresenius SE did just that on Wednesday....
...Fresenius , the dialysis company, dragged German markets lower....
...Following the example of Fresenius, Henkel and Merck – each a Dax-30 company – Bertelsmann is to change its legal status to that of a Kommanditgesellschaft auf Aktien (KgaA)....
...Fresenius Medical , the dialysis provider, rose 2.2 per cent to €49.31 in Frankfurt after Citigroup raised its price target to €55....
...In Berlin, healthcare group Fresenius was the biggest gainer, jumping 3.4 per cent to €56.55 after Deutsche Bank raised its price target on the stock and maintained a “buy” rating following its second-quarter...
...Fresenius added 4.6 per cent to €51.18 while Fresenius Medical Care advanced 4.3 per cent to €38.68. The FTSE Eurofirst 300 edged up 0.2 per cent to 1013.66....
...Meanwhile, Germany’s Fresenius Medical Care gained 0.1 per cent to €34.32, but French pharmaceutical company Sanofi-Aventis slipped 0.2 per cent to €43.37....
...German medical equipment manufacturer Fresenius rose 2.1 per cent to €33.60 as investors looked for defensive safe havens....
...Fresenius Medical Care, which provides kidney dialysis services to 10 per cent of patients worldwide, rose 2.3 per cent to €33.97 as fears about the impact of new US Medicare restrictions receded....
...Of the fallers, Fresenius lost 3.9 per cent to €57.55 as Deutsche Bank and West LB placed 3.56m shares in the German healthcare group....
...Jimmy Yates, a trader at CMC Markets, said Fresenius Medical Care’s gains were purely speculative, based on legislation that has yet to be passed....
...As SEs, both Allianz and Fresenius will appoint employee representatives from other EU countries to their supervisory boards....
...Positive broker comment also sent German healthcare group Fresenius up 2.4 per cent to €163.15....
...Germany’s Fresenius Medical Care was up 2.6 per cent after the company announced it had entered a a new sourcing and supply treaty with Amgen in the US....
...Fresenius Medical Care, the world’s largest provider of dialysis equipment and services, was among the top 10 gainers, rising 2 per cent to €80.10....
...In the same sector, dialysis company Fresenius Medical Care fell 1.7 per cent to €61.69 after it said it was buying Haemotec of Canada but gave no financial details....
International Edition